0.6597
price up icon3.56%   0.0227
after-market 시간 외 거래: .65 -0.0097 -1.47%
loading
전일 마감가:
$0.637
열려 있는:
$0.64
하루 거래량:
1.53M
Relative Volume:
1.70
시가총액:
$56.84M
수익:
$2.24M
순이익/손실:
$-136.67M
주가수익비율:
-0.2881
EPS:
-2.29
순현금흐름:
$-102.08M
1주 성능:
+13.70%
1개월 성능:
+10.97%
6개월 성능:
-26.70%
1년 성능:
-72.28%
1일 변동 폭
Value
$0.63
$0.675
1주일 범위
Value
$0.5666
$0.675
52주 변동 폭
Value
$0.3418
$2.5199

Century Therapeutics Inc Stock (IPSC) Company Profile

Name
명칭
Century Therapeutics Inc
Name
전화
215-981-4000
Name
주소
25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA
Name
직원
165
Name
트위터
Name
다음 수익 날짜
2025-03-19
Name
최신 SEC 제출 서류
Name
IPSC's Discussions on Twitter

IPSC을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
IPSC
Century Therapeutics Inc
0.6597 49.57M 2.24M -136.67M -102.08M -2.29
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Century Therapeutics Inc Stock (IPSC) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-08-08 개시 Rodman & Renshaw Buy
2023-08-28 다운그레이드 JP Morgan Overweight → Neutral
2022-12-27 개시 Chardan Capital Markets Buy
2022-10-31 개시 Guggenheim Buy
2022-10-10 개시 Canaccord Genuity Buy
2022-05-23 개시 H.C. Wainwright Buy
2022-05-12 개시 William Blair Mkt Perform
2021-07-13 개시 BofA Securities Buy
2021-07-13 개시 JP Morgan Overweight
2021-07-13 개시 Piper Sandler Overweight
모두보기

Century Therapeutics Inc 주식(IPSC)의 최신 뉴스

pulisher
Jul 24, 2025

What analysts say about Century Therapeutics Inc. stockJaw-dropping returns - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

Layoff Tracker: Flagship Unicorns Tessera, Generate:Biomedicines Downsize - BioSpace

Jul 24, 2025
pulisher
Jul 23, 2025

Century Therapeutics Inc. Stock Analysis and ForecastTremendous growth potential - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Century Therapeutics Inc. stock priceExceptional profit velocity - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

All You Need to Know About Century Therapeutics (IPSC) Rating Upgrade to Strong Buy - Yahoo Finance

Jul 21, 2025
pulisher
Jul 20, 2025

Is Century Therapeutics Inc. a good long term investmentMarket-leading capital gains - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 18, 2025

What institutions are buying Century Therapeutics Inc. stock nowFree Step-by-Step Investment Guide - Newser

Jul 18, 2025
pulisher
Jul 16, 2025

University City biotech Century Therapeutics is cutting 72 jobs, about half its workforce - MSN

Jul 16, 2025
pulisher
Jul 15, 2025

Why Century Therapeutics Inc. stock attracts strong analyst attentionMarket Trend Watch - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Finance Watch: Karyopharm Cuts Jobs In Cash Crunch; Pacira’s Layoffs Attributed To Efficiency - insights.citeline.com

Jul 15, 2025
pulisher
Jul 15, 2025

Century Therapeutics to Present Preclinical Data at EULAR 2025 Congress - MSN

Jul 15, 2025
pulisher
Jul 15, 2025

How Century Therapeutics Inc. stock performs during market volatilityFree Stock Market Query - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Century Therapeutics Inc. stock price move sharplyRisk Limited High Gain Trades - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Despite Fast-paced Momentum, Century Therapeutics (IPSC) Is Still a Bargain Stock - Yahoo Finance

Jul 15, 2025
pulisher
Jul 15, 2025

Why OBIO stock attracts strong analyst attentionHigh Yield Stock Selection - Newser

Jul 15, 2025
pulisher
Jul 10, 2025

Company’s Banking Stock: Dissecting a 51.83% Quarterly Revenue Decline Amid Growth - investchronicle.com

Jul 10, 2025
pulisher
Jul 08, 2025

Century Therapeutics (NASDAQ:IPSC) Shares Down 0.9% – What’s Next? - Defense World

Jul 08, 2025
pulisher
Jul 07, 2025

CFO changes at Biocryst, Xenon, Century, Pyxis - biocentury.com

Jul 07, 2025
pulisher
Jul 07, 2025

Century Therapeutics to reduce headcount by 51% - MarketScreener

Jul 07, 2025
pulisher
Jul 07, 2025

Century Therapeutics Announces Major Workforce Reduction - TipRanks

Jul 07, 2025
pulisher
Jun 25, 2025

Century Therapeutics (IPSC) Is Attractively Priced Despite Fast-paced Momentum - Nasdaq

Jun 25, 2025
pulisher
Jun 20, 2025

Head-To-Head Contrast: Quince Therapeutics (NASDAQ:QNCX) and Century Therapeutics (NASDAQ:IPSC) - Defense World

Jun 20, 2025
pulisher
Jun 16, 2025

Century Therapeutics Holds Annual Stockholder Meeting By Investing.com - Investing.com South Africa

Jun 16, 2025
pulisher
Jun 16, 2025

Century Therapeutics Holds Annual Stockholder Meeting - Investing.com Australia

Jun 16, 2025
pulisher
Jun 16, 2025

Century Therapeutics Holds 2025 Annual Stockholders Meeting - TipRanks

Jun 16, 2025
pulisher
Jun 14, 2025

66,797 Shares in Century Therapeutics, Inc. (NASDAQ:IPSC) Acquired by Two Sigma Investments LP - Defense World

Jun 14, 2025
pulisher
Jun 10, 2025

Jane Street Group LLC Increases Stock Holdings in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Century Therapeutics, Inc. (NASDAQ:IPSC) Shares Acquired by Squarepoint Ops LLC - Defense World

Jun 09, 2025
pulisher
Jun 09, 2025

Two Sigma Advisers LP Takes $52,000 Position in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

Nuveen Asset Management LLC Raises Holdings in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World

Jun 07, 2025

Century Therapeutics Inc (IPSC) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
자본화:     |  볼륨(24시간):